138 related articles for article (PubMed ID: 33893685)
1. Between responsibility and desire: Accounts of reproductive decisions from those at risk for or affected by late-onset neurological diseases.
Mendes Á; Sequeiros J; Clarke AJ
J Genet Couns; 2021 Oct; 30(5):1480-1490. PubMed ID: 33893685
[TBL] [Abstract][Full Text] [Related]
2. Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I.
Rolim L; Leite A; Lêdo S; Paneque M; Sequeiros J; Fleming M
Clin Genet; 2006 Apr; 69(4):297-305. PubMed ID: 16630162
[TBL] [Abstract][Full Text] [Related]
3. Subjects At-Risk for Genetic Diseases in Portugal: Illness Representations.
Leite Â; Dinis MA; Sequeiros J; Paúl C
J Genet Couns; 2016 Feb; 25(1):79-89. PubMed ID: 25986962
[TBL] [Abstract][Full Text] [Related]
4. Subjects at Risk for Genetic Late-Onset Neurological Diseases: Objective Knowledge.
Leite Â; Leite F; Dinis MAP
Public Health Genomics; 2017; 20(3):158-165. PubMed ID: 28813711
[TBL] [Abstract][Full Text] [Related]
5. Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal.
Paneque M; Félix J; Mendes Á; Lemos C; Lêdo S; Silva J; Sequeiros J
Acta Med Port; 2019 Apr; 32(4):295-304. PubMed ID: 31067424
[TBL] [Abstract][Full Text] [Related]
6. Mid- and long-term anxiety levels associated with presymptomatic testing of Huntington's disease, Machado-Joseph disease, and familial amyloid polyneuropathy.
Lêdo S; Leite Â; Souto T; Dinis MA; Sequeiros J
Braz J Psychiatry; 2016 Feb; 38(2):113-20. PubMed ID: 26870910
[TBL] [Abstract][Full Text] [Related]
7. Choosing not to know: accounts of non-engagement with pre-symptomatic testing for Machado-Joseph disease.
Mendes Á; Paneque M; Clarke A; Sequeiros J
Eur J Hum Genet; 2019 Mar; 27(3):353-359. PubMed ID: 30573801
[TBL] [Abstract][Full Text] [Related]
8. Discredited legacy: Stigma and familial amyloid polyneuropathy in Northwestern Portugal.
Mendes Á; Sousa L; Sequeiros J; Clarke A
Soc Sci Med; 2017 Jun; 182():73-80. PubMed ID: 28433926
[TBL] [Abstract][Full Text] [Related]
9. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
10. A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.
Alves-Ferreira M; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
Mol Neurobiol; 2018 May; 55(5):3676-3683. PubMed ID: 28527106
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study.
Inês M; Coelho T; Conceição I; Duarte-Ramos F; de Carvalho M; Costa J
Neuroepidemiology; 2018; 51(3-4):177-182. PubMed ID: 30153683
[TBL] [Abstract][Full Text] [Related]
12. Clinical and therapeutic implications of presymptomatic gene testing for familial amyloidotic polyneuropathy (FAP).
Sales-Luís Mde L; Conceição I; de Carvalho M
Amyloid; 2003 Aug; 10 Suppl 1():26-31. PubMed ID: 14640039
[TBL] [Abstract][Full Text] [Related]
13. Disease knowledge and attitudes toward predictive testing and prenatal diagnosis in families with Machado-Joseph disease from the Azores Islands (Portugal).
Lima M; Kay T; Vasconcelos J; Mota-Vieira L; Gonzalez C; Peixoto A; Abade A; MacLeod P; Graca R; Santos J
Community Genet; 2001; 4(1):36-42. PubMed ID: 11493751
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
[TBL] [Abstract][Full Text] [Related]
15. Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
Schmidt HH; Barroso F; González-Duarte A; Conceição I; Obici L; Keohane D; Amass L
Muscle Nerve; 2016 Sep; 54(3):353-60. PubMed ID: 27273296
[TBL] [Abstract][Full Text] [Related]
16. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
Ikeda S; Nakazato M; Ando Y; Sobue G
Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
[TBL] [Abstract][Full Text] [Related]
17. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
Rudolph T; Kurz MW; Farbu E
Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975
[TBL] [Abstract][Full Text] [Related]
18. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
[TBL] [Abstract][Full Text] [Related]
19. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
[TBL] [Abstract][Full Text] [Related]
20. Family studies of the genetic abnormality in transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy.
Saraiva MJ; Birken S; Costa PP; Goodman DS
Ann N Y Acad Sci; 1984; 435():86-100. PubMed ID: 6099706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
